Longevity Lab Report

Evidence history

Follow the evidence behind a claim

See when an assessment was recorded, what it concluded and which sources support it. Save subjects in this browser to find their records again.

This history begins on November 15, 2026. Its first entries are baseline assessments of older research. No later evidence updates or historical grade changes have been recorded here yet. A baseline entry does not mean a conclusion changed.

Your evidence watchlist

Save a subject to find its evidence assessment again. This list stays in this browser. It does not send notifications or subscribe you to email.

Loading saved subjects…

Public assessment history

  1. · Baseline assessment

    Did a daily multivitamin prevent cancer in COSMOS?

    COSMOS did not establish a reduction in total invasive cancer during its follow-up. This result does not settle every use of a multivitamin.

    First entry in this evidence history. This is a dated assessment of existing research, not a newly published study or a change to a library grade.

    Conclusion changed: not applicable — first entry.

  2. · Baseline assessment

    What did VITAL find about fish oil and heart events?

    VITAL did not establish a reduction in its primary cardiovascular outcome. A positive result for prescription EPA in a different population cannot be assumed to apply to an ordinary fish-oil supplement.

    First entry in this evidence history. This is a dated assessment of existing research, not a newly published study or a change to a library grade.

    Conclusion changed: not applicable — first entry.

  3. · Baseline assessment

    Did glucosamine relieve knee pain in GAIT?

    GAIT did not establish an overall pain benefit for glucosamine hydrochloride alone. Its exploratory combination-treatment subgroup is not proof that glucosamine alone works.

    First entry in this evidence history. This is a dated assessment of existing research, not a newly published study or a change to a library grade.

    Conclusion changed: not applicable — first entry.

  4. · Baseline assessment

    How large was the magnesium bisglycinate sleep result?

    The trial found a small additional improvement in reported insomnia symptoms over four weeks. It did not establish an objective sleep benefit or superiority to other magnesium forms.

    First entry in this evidence history. This is a dated assessment of existing research, not a newly published study or a change to a library grade.

    Conclusion changed: not applicable — first entry.

  5. · Baseline assessment

    What does the psilocybin mouse survival result mean?

    This study cannot establish a human lifespan benefit. More treated mice survived to the study endpoint, but the experiment ended before their full lifespans were observed.

    First entry in this evidence history. This is a dated assessment of existing research, not a newly published study or a change to a library grade.

    Conclusion changed: not applicable — first entry.